-
Peng CHENG
Regional Partner / Beijing
-
Tel +86-21-6061-3498
Email tonypeng@zhonglun.com
-
Practices
Private Equity & Investment Funds, Chinese Mainland Capital Markets, Hong Kong & Overseas Capital Markets
Peng CHENG
Mr. Peng has extensive experience in domestic and cross-border investments and corporate finance. He regularly represents prominent USD and RMB funds, large private enterprises, and startups across all stages of financing, from angel and venture capital to private equity rounds. He is particularly focused on pre-IPO financings for companies targeting Chinese mainland exchanges. His deep understanding of domestic capital markets allows him to deliver strategic, top-tier legal counsel to his clients.
To date, Mr. Peng has guided dozens of companies through successful domestic and offshore IPOs. He is highly regarded for his specialized expertise in dismantling red-chip structures to facilitate A-share listings.
Drawing on his extensive work with new-economy startups, Mr. Peng provides tailored, end-to-end legal solutions. He supports clients through the entire corporate lifecycle, with a practice covering private equity, employee stock ownership plans (ESOPs), M&A, capital markets, and general corporate advisory.
Representative Matters
Private Equity
Advised BioTrack Capital on its Series B investment in SMT Group
Advised BioTrack Capital on its Series A investment in Alpmed
Advised BioTrack Capital on its Series A and Series B investments in Seeneuro Medical
Advised Blue Lake Capital on its Series A investment in SENSING Technology
Advised Cash Capital on its Series A investment in Vision Medicals
Advised Ameba Capital on its investment in Porotech
Advised Ameba Capital on multiple rounds of investment in Coutloot
Advised Ameba Capital on multiple rounds of investment in Collov
Advised Jushuitan on dozens of strategic investments, including in Jishiyu Chat, Dian Plus, and Channelwill
Advised Sinopharm Capital and other investors on their Series C investment in Sinotau Pharmaceutical Group
Advised China Broadband Capital on its Series C investment in Persagy
Advised Tsinghua Holdings Capital on its investment in a military communication equipment company
Advised Double Hundred Fund on its investments in multiple infrastructure projects
Advised Morgan Stanley's RMB fund on its investments in multiple new-economy projects
Advised Shenogen Pharma Group on multiple private equity financing rounds
Advised Lanhu on multiple private equity financing rounds
Advised Waytous on its Series B financing
Advised Poweroak on its Series B financing
Advised Linkmore on its Series A and Series A+ financings
Advised Meishe SDK on its Series A strategic financing
Advised 10K Genomics on its Series A financing
Advised Uroaming on its Series A and Series B financings
Capital Markets
Advised Dongpeng Ceramics on its A-share IPO on the Shenzhen Stock Exchange's ChiNext market
Advised an internet security enterprise on its A-share IPO on the Shanghai Stock Exchange's STAR Market
Advised the underwriters on GreenTree's US IPO on the New York Stock Exchange (NYSE)
-
Bar Admissions/Professional Qualifications
PRC Bar, 2019
-
Education
LL.M., Queen Mary University of London, 2011
LL.B., East China University of Political Science and Law, 2009 -
Professional Experience
Regional Partner, Non-Equity Partner, and Associate, Zhong Lun Law Firm, 2021 to present
Associate, King & Wood Mallesons, 2014-2021
Associate, King & Capital Law Firm, 2013-2014 -
Languages
Chinese
English